Table S2 from Preclinical Development of MGC028, an ADAM9-Targeted, Glycan-Linked, Exatecan-Based Antibody–Drug Conjugate for the Treatment of Solid Cancers

Read full text Summarise with VIRAT
Authors: Juniper A. Scribner, Jennifer G. Brown, Thomas Son, Linda X. Jin, Carroll McKenzie, Viktoriya Nam, Curtis Bush, Dienis Quinonez, Delta Ford, James K. Tamura, Sergey N. Gorlatov, Angela Summers
+8 more Monirath Hav, Hua Li, Neel Kamal Sharma, Xiaoyan Zhang, Gundo Diedrich, Shelley Ruth Butler, Ezio Bonvini, Deryk T. Loo
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Equilibrium dissociation constant of binding of MGC028 and MGA027 to human and cynomolgus monkey ADAM9

Fields of Study & Subjects

Monoclonal and Polyclonal Antibodies Research Toxin Mechanisms and Immunotoxins Protein Degradation and Inhibitors

Publication details

Publication date
2 April 2026
Language
EN